Eton Pharmaceuticals, Inc. (ETON)
50.19
+0.97
(+1.97%)
USD |
NASDAQ |
Oct 20, 16:00
50.96
+0.77
(+1.53%)
After-Hours: 05:24
Eton Pharmaceuticals Gross Profit Margin (Quarterly) : 67.61% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 67.61% |
| March 31, 2026 | 60.72% |
| December 31, 2025 | 61.56% |
| September 30, 2025 | 34.97% |
| June 30, 2025 | 63.00% |
| March 31, 2025 | 57.06% |
| December 31, 2024 | 55.60% |
| September 30, 2024 | 61.04% |
| June 30, 2024 | 62.00% |
| March 31, 2024 | 62.85% |
| December 31, 2023 | 49.64% |
| September 30, 2023 | 62.65% |
| June 30, 2023 | 80.70% |
| March 31, 2023 | 63.08% |
| December 31, 2022 | 74.84% |
| Date | Value |
|---|---|
| September 30, 2022 | 62.69% |
| June 30, 2022 | 62.69% |
| March 31, 2022 | 67.00% |
| December 31, 2021 | 95.40% |
| September 30, 2021 | 20.39% |
| June 30, 2021 | 95.57% |
| March 31, 2021 | 85.33% |
| December 31, 2020 | -270.4% |
| September 30, 2020 | |
| June 30, 2020 | -860.0% |
| March 31, 2020 | -84.85% |
| December 31, 2019 | 1.31% |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Aquestive Therapeutics, Inc. | 70.93% |
| Pfizer Inc. | 62.94% |
| Elite Pharmaceuticals, Inc. | 40.61% |
| Daré Bioscience, Inc. | -294.5% |
| Liquidia Corp. | 93.10% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 42.17% |
| Return on Assets | 12.40% |
| Return on Invested Capital | 20.90% |
| Profit Margin (Quarterly) | 30.80% |
| Operating Margin (Quarterly) | 34.04% |
| Return on Net Operating Assets | 18.28% |